Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN) shares traded down 3.3% on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company’s 50-day moving average price is GBX 3.87 and its two-hundred day moving average price is GBX 3.95. The company has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Transactions at Eden Research

In other Eden Research news, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek purchased 256,000 shares of the firm’s stock in a transaction dated Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.